Skip to main content
CVS
NYSE Life Sciences

安泰(Aetna)同意支付1.177亿美元给DOJ以解决《虚假申诉法》(False Claims Act)指控

feedReported by Reuters
Sentiment info
Negative
Importance info
7
Price
$76.18
Mkt Cap
$96.917B
52W Low
$58.35
52W High
$85.15
Market data snapshot near publication time

summarizeSummary

CVS Health的子公司安泰(Aetna)已经同意支付1.177亿美元给美国司法部(DOJ)以解决《虚假申诉法》(False Claims Act)违规指控。该笔支付代表了公司过去的不当行为所带来的经济处罚,凸显了公司的法律和合规风险。虽然金额相对于CVS Health近970亿美元的市场资本化来说并不重大,但这确实是一个实际的经济损失。这一事件与最近关于谷歌云(Google Cloud)合作伙伴关系和21亿美元住房投资的积极新闻是不同的,公司最近的10-K报告也强调了重大财务费用,包括57亿美元的商誉减值。投资者可能会密切关注有关指控性质和潜在持续合规风险的任何进一步细节,并将审阅SEC和CIK相关文件,包括Form 4和8-K报告,以获取更多信息。

在该公告发布时,CVS的交易价格为$76.18,交易所为NYSE,所属行业为Life Sciences,市值约为$969.2亿。 52周交易区间为$58.35至$85.15。 这则新闻被评估为消极市场情绪,重要性评分为7/10。 来源:Reuters。


show_chartPrice Chart

Share this article

Copied!

feed CVS - Latest Insights

CVS
Apr 24, 2026, 4:04 PM EDT
Source: Wiseek News
Importance Score:
7
CVS
Apr 16, 2026, 12:53 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CVS
Apr 09, 2026, 5:40 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CVS
Apr 03, 2026, 4:05 PM EDT
Filing Type: DEFA14A
Importance Score:
7
CVS
Apr 03, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
8
CVS
Apr 01, 2026, 3:07 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CVS
Mar 30, 2026, 1:12 PM EDT
Source: Dow Jones Newswires
Importance Score:
7
CVS
Mar 30, 2026, 2:47 AM EDT
Source: ShareCast
Importance Score:
8
CVS
Mar 24, 2026, 12:34 PM EDT
Source: Reuters
Importance Score:
7
CVS
Mar 19, 2026, 4:08 PM EDT
Filing Type: 8-K
Importance Score:
7